AKT1 and gastric cancer: Some studies have indicated that FGA knockout via CRISPR/Cas9 genome editing or FGA knockdown via shRNA interference leads to enhanced cell proliferation, migration, invasion, and metastasis of lung ADC cells via the integrin–AKT signaling pathway [32], and in gastric cancer cells via modulation of the FAK–ERK pathway [27].